This proposal describes the career development plan for the proposed Sickle Cell Scholar. The next generation of clinical researchers in sickle cell disease (SCD) will need to include individuals with the skills, attitudes, early research training and experience to capitalize on rapidly developing progress in SCD research. In developing this plan, we will use established research infrastructure, including our Graduate Training Program in Clinical Investigation (GTPCI) at the Johns Hopkins University School of Medicine and Johns Hopkins University Bloomberg School of Public Health and a mentored research project to provide intensive training in clinical research and methodology for the Sickle Cell Scholar.
Our specific aims are: a) To identify, train and develop a creative and successful clinical investigator, with the capability to interact with, participate in, and lead multidisciplinary teams involved in clinical research, address complex problems and become a national leader in SCD research;b) To provide the trainee with the requisite skills, knowledge, attitude and experience for a successful career in clinical research in SCD. This training will include exposure to national and international leaders and curriculum in the multiple disciplines necessary for successful clinical research, including clinical trials design, epidemiology, statistics, research ethics and human subjects protection, as well as a research project developed by the Scholar in conjunction with his mentor;c) To provide access to the rich mentoring environment of the Johns Hopkins University School of Medicine and School of Public Health to provide optimal exposure of the Sickle Cell Scholar to research experiences and training. Careful and extensive mentoring will be the cornerstone of this effort, with exposure to and involvement in cutting edge research. Through this program, we ultimately aim to develop a Sickle Cell Scholar, who will become a creative, independent investigator, care for patients with SCD and assume a leadership role in SCD patient-oriented research.
|Bundy, David G; Muschelli, John; Clemens, Gwendolyn D et al. (2016) Preventive Care Delivery to Young Children With Sickle Cell Disease. J Pediatr Hematol Oncol 38:294-300|
|Minkovitz, Cynthia S; Grason, Holly; Ruderman, Marjory et al. (2016) Newborn Screening Programs and Sickle Cell Disease: A Public Health Services and Systems Approach. Am J Prev Med 51:S39-47|
|Lance, Eboni I; Comi, Anne M; Johnston, Michael V et al. (2015) Risk Factors for Attention and Behavioral Issues in Pediatric Sickle Cell Disease. Clin Pediatr (Phila) 54:1087-93|
|Bundy, David G; Abrams, Michael T; Strouse, John J et al. (2015) Transcranial Doppler screening of Medicaid-insured children with sickle cell disease. J Pediatr 166:188-90|
|Lance, Eboni I; Casella, James F; Everett, Allen D et al. (2014) Proteomic and biomarker studies and neurological complications of pediatric sickle cell disease. Proteomics Clin Appl 8:813-27|
|Burnett, Arthur L; Anele, Uzoma A; Trueheart, Irene N et al. (2014) Randomized controlled trial of sildenafil for preventing recurrent ischemic priapism in sickle cell disease. Am J Med 127:664-8|
|Sadreameli, Sara Christina; Reller, Megan E; Bundy, David G et al. (2014) Respiratory syncytial virus and seasonal influenza cause similar illnesses in children with sickle cell disease. Pediatr Blood Cancer 61:875-8|
|Musicki, Biljana; Bivalacqua, Trinity J; Champion, Hunter C et al. (2014) Sildenafil promotes eNOS activation and inhibits NADPH oxidase in the transgenic sickle cell mouse penis. J Sex Med 11:424-30|
|Lagoda, Gwen; Sezen, Sena F; Hurt, K Joseph et al. (2014) Sustained nitric oxide (NO)-releasing compound reverses dysregulated NO signal transduction in priapism. FASEB J 28:76-84|
|Bean, Christopher J; Boulet, Sheree L; Yang, Genyan et al. (2013) Acute chest syndrome is associated with single nucleotide polymorphism-defined beta globin cluster haplotype in children with sickle cell anaemia. Br J Haematol 163:268-76|
Showing the most recent 10 out of 31 publications